Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis

Table 1

The clinical characteristics of liver tumor patients from TCGA dataset.

Characteristics	Training ()	Validation ()	Total ()	value
Age
Gender				1.00
FEMALE	53 (15.87%)	52 (15.57%)	105 (31.44%)
MALE	115 (34.43%)	114 (34.13%)	229 (68.56%)
Grade				0.94
G1	27 (8.08%)	25 (7.49%)	52 (15.57%)
G2	80 (23.95%)	76 (22.75%)	156 (46.71%)
G3	53 (15.87%)	56 (16.77%)	109 (32.63%)
G4	5 (1.50%)	7 (2.10%)	12 (3.59%)
Unknown	3 (0.90%)	2 (0.60%)	5 (1.50%)
Stage				0.46
Stage I	80 (23.95%)	78 (23.35%)	158 (47.31%)
Stage II	31 (9.28%)	43 (12.87%)	74 (22.16%)
Stage III	3 (0.90%)	0 (0.0e+0%)	3 (0.90%)
Stage IIIA	31 (9.28%)	28 (8.38%)	59 (17.66%)
Stage IIIB	3 (0.90%)	4 (1.20%)	7 (2.10%)
Stage IIIC	6 (1.80%)	3 (0.90%)	9 (2.69%)
Stage IV	1 (0.30%)	0 (0.0e+0%)	1 (0.30%)
Stage IVB	1 (0.30%)	1 (0.30%)	2 (0.60%)
Unknown	12 (3.59%)	9 (2.69%)	21 (6.29%)
T				0.28
T1	86 (25.75%)	79 (23.65%)	165 (49.40%)
T2	32 (9.58%)	47 (14.07%)	79 (23.65%)
T2a	1 (0.30%)	0 (0.0e+0%)	1 (0.30%)
T2b	0 (0.0e+0%)	1 (0.30%)	1 (0.30%)
T3	23 (6.89%)	20 (5.99%)	43 (12.87%)
T3a	16 (4.79%)	8 (2.40%)	24 (7.19%)
T3b	1 (0.30%)	4 (1.20%)	5 (1.50%)
T4	7 (2.10%)	6 (1.80%)	13 (3.89%)
TX	1 (0.30%)	0 (0.0e+0%)	1 (0.30%)
Unknown	1 (0.30%)	1 (0.30%)	2 (0.60%)
M				0.83
M0	120 (35.93%)	121 (36.23%)	241 (72.16%)
M1	2 (0.60%)	1 (0.30%)	3 (0.90%)
MX	46 (13.77%)	44 (13.17%)	90 (26.95%)
N				0.24
N0	115 (34.43%)	119 (35.63%)	234 (70.06%)
N1	3 (0.90%)	0 (0)	3 (0.90%)
NX	50 (14.97%)	46 (13.77%)	96 (28.74%)
Unknown	0 (0)	1 (0.30%)	1 (0.30%)